BackBackMenuCloseClosePlusPlusSearchUluleUluleUluleChatFacebookInstagramLinkedInTwitterYouTubefacebooktwitterB Corporation

The psychedelic revolution in health care

Documentary: magic mushrooms show promise as depression remedy

About the project

Worldwide millions of people are suffering from a range of psychological disorders, including depression, anxiety, addiction, and post-traumatic stress disorder. For many of them, the currently available treatments are insufficient. Recent scientific research shows that psychotherapy in combination with psychedelics could be an important way forward in treating these patients and overcoming their conditions.

However, these promising results are largely being overlooked, due to the controversial nature of psychedelics. The aim of this documentary is to break the taboo and inform the public of the potential benefits and risks of psychedelics in the context of psychological disorders. The fact that millions of people are still unnecessarily suffering from conditions for which psychedelics could prove effective, stresses the importance of this 'Psychedelic Renaissance'.

At the Breaking Convention conference in London we already interviewed prominent scientists. The videos below are selected fragments of these interviews. We intend to interview participants of the key studies already conducted and to counterpose them to patients for whom no currently available treatment has worked. 

For which conditions could psychedelics be effective?

Psychedelic drugs thus seem very promising, but why? The main reason is that these treatments try to tackle the underlying problems, whereas the currently available treatments focus on the suppression of symptoms.

Why are the current treatments insufficient?

This documentary is devoted to MDMA and psilocybin, the active component of ‘magic mushrooms’, since most psychedelic research also focuses on these substances.

Could MDMA offer a solution for people suffering from PTSD?

Whereas MDMA seems especially promising for PTSD, the research on psilocybin suggests it can be used for tackling depression and addictions. The underlying mechanism again differs fundamentally from the currently available treatments.

What happens during a psychedelic experience?

With this documentary we aim to inform the public in an unbiased way of the possible benefits and risks of psychedelics in mental healthcare. We will give an overview of the current scientific state of affairs, with special attention to the belgian context. We hope to break the current taboo and to stimulate the debate.

The fact that millions of people keep on suffering unnecessarily from conditions for which psychedelics could provide a solution, gives this story its urgency.

What are the funds for?

Our first goal (€5,500) has been reached. Our second goal is €10,600.

We are going to use the extra funds for an audiovisual upgrade of the documentary (mainly animations), in order to reach more people.

Your support will go to the production and post production of the documentary: 

Travel expenses (United States, UK, Belgium and The Netherlands);

Color grading;

Online Promotion;

Music;

Animations;

Audio mixing;

Subtitling.

About the project owner

Robin Van Nuffel studied Film, Journalism and International Politics. After six years at a video production company, he became an independent videographer and founded Memory Lane.

Andries De Smet is doctor of Philosophy and MSc in Film and Television studies

Would you like to know more about the scientific research?

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study: http://www.thelancet.com/journals/lanpsy/article/PIIS2215-0366%2816%2930065-7/fulltext

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial: http://journals.sagepub.com/doi/abs/10.1177/0269881116675513

The safety and efficacy of MDMA-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study: http://journals.sagepub.com/doi/abs/10.1177/0269881110378371

Overview psychedelic research: http://www.maps.org/research